StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
SHPHShuttle Pharmaceuticals Holdings, Inc.
stockpulse.co.kr
Nasdaq
$5.00▼ 1.57%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.2MShares out 0.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

11
  • 2d agoAfter-hours26.10.23 05:30
    8-KKey event#●●●

    Shuttle Pharmaceuticals Holdings, Inc.Bullish

    Shuttle Pharmaceuticals Holdings, Inc. dismissed its independent registered public accounting firm, Forvis Mazars, LLP, effective October 16, 2026. The company has previously disclosed material weaknesses in its internal control over financial reporting and has not yet engaged a successor accounting firm.…more

    $5.00-1.57%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.24Regular26.09.25 01:01
    10-QEarnings

    Shuttle Pharmaceuticals Holdings, Inc.

    Shuttle Pharmaceuticals Holdings reported its financial results for the second quarter of 2026, highlighting ongoing operating losses and active capital raising efforts. The company continues to issue convertible preferred stock and warrants to secure necessary operating capital, reflecting significant financial uncertainty.…more

    $5.00-1.57%vs prev close
    View filingShare
  • 9.24Regular26.09.25 01:00
    8-K/AKey event

    Shuttle Pharmaceuticals Holdings, Inc.

    Shuttle Pharmaceuticals Holdings, Inc. filed an amendment to its Form 8-K to clarify that the actual number of pre-funded warrants issued as of September 9, 2026, is 9,741,751. This corrects the previously disclosed figure, which represented the maximum potential issuance rather than the actual amount issued.…more

    $5.00-1.57%vs prev close
    View filingShare

10 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.24After-hours26.09.25 07:02
    #●●●

    Shuttle Pharmaceuticals Reports Q2 EPS of $(3.10)

    Shuttle Pharmaceuticals reported a quarterly loss of $3.10 per share, showing a significant improvement from the $32.90 loss in the same period last year. Despite the reduced losses, the company remains unprofitable.…more

    $5.00-1.57%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga